BCL6 and neoplasm: Sorted CD62L+ OT-1 T cells from Bcl6+/+ and Bcl6fl/fl mice (Fig 4C) were transferred into LLC-OVA–transplanted CD45.1 wild-type mice, and tumor-infiltrating cells were analyzed 7 days later.